Reviewing Global Medical REIT (GMRE) and Its Competitors

Global Medical REIT (NYSE: GMRE) is one of 23 public companies in the “Healthcare REITs” industry, but how does it compare to its peers? We will compare Global Medical REIT to related companies based on the strength of its institutional ownership, valuation, dividends, analyst recommendations, profitability, earnings and risk.

Profitability

Get Global Medical REIT alerts:

This table compares Global Medical REIT and its peers’ net margins, return on equity and return on assets.

Net Margins

Return on Equity

Return on Assets

Global Medical REIT

-19.98%

-2.86%

-1.39%

Global Medical REIT Competitors

35.60%

7.69%

3.77%

Institutional and Insider Ownership

41.0% of Global Medical REIT shares are owned by institutional investors. Comparatively, 82.7% of shares of all “Healthcare REITs” companies are owned by institutional investors. 16.5% of Global Medical REIT shares are owned by insiders. Comparatively, 6.2% of shares of all “Healthcare REITs” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Global Medical REIT’s peers have higher revenue and earnings than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

Global Medical REIT has a beta of -0.18, suggesting that its stock price is 118% less volatile than the S&P 500. Comparatively, Global Medical REIT’s peers have a beta of 0.33, suggesting that their average stock price is 67% less volatile than the S&P 500.

Dividends

Global Medical REIT pays an annual dividend of $0.80 per share and has a dividend yield of 9.7%. Global Medical REIT pays out -296.3% of its earnings in the form of a dividend. As a group, “Healthcare REITs” companies pay a dividend yield of 5.5% and pay out 142.8% of their earnings in the form of a dividend. Global Medical REIT is clearly a better dividend stock than its peers, given its higher yield and lower payout ratio.

Analyst Ratings

This is a summary of current ratings and target prices for Global Medical REIT and its peers, as reported by MarketBeat.com.

Sell Ratings

Hold Ratings

Buy Ratings

Strong Buy Ratings

Rating Score

Global Medical REIT

0

1

5

0

2.83

Global Medical REIT Competitors

143

758

682

12

2.35

Global Medical REIT currently has a consensus target price of $10.75, suggesting a potential upside of 30.30%. As a group, “Healthcare REITs” companies have a potential upside of 7.00%. Given Global Medical REIT’s stronger consensus rating and higher possible upside, research analysts clearly believe Global Medical REIT is more favorable than its peers.

Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and the leasing of these facilities to clinical operators with market share. The Company’s strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market operators under long-term triple-net leases.